About us

Inflammation is a reaction of the immune system that enables it to fight diseases effectively. But sometimes inflammation is dysregulated and triggers chronic pathologies, such as autoimmune diseases or cancers, or overreacts in an uncontrolled manner to certain pathogens, as in the case of COVID-19. Inflammation-related phenomena may also explain transplant rejection or increased susceptibility to infections in transplant recipients with weakened immune systems. Many therapeutic strategies target the regulation of inflammation: modulation of inflammation in arthritis or other inflammatory diseases, immunotherapy for cancer, or adjuvants that make certain vaccines more effective.

Inflammation has been the subject of significant research and teaching activities in Geneva for several years. The thirty research groups that are part of the Geneva Centre for Inflammation Research (GCIR) work on one or more aspects or pathologies related to inflammation, in basic research or clinical medicine, in close collaboration with the Geneva University Hospitals (HUG).

The main objectives of the centre are to pool resources, foster multidisciplinary collaborations and attract young talent. The centre also provides state-of-the-art training for clinicians. In addition, in order to accelerate the rapid translation of research results into medical advances for the population, the centre serves as an interface between academia and industry. The research topics of the centre can be classified into three main areas: immune dysfunction, host response to pathogens, and immune cell trafficking and maturation.

If you want to know the latest news from the GCIR, check our News section or follow us on X and LinkedIn!

See our summary in French / Lire notre résumé en français 

 

COORDINATORS AND Steering committee